• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠脑轴:深入了解微生物群在帕金森病中的作用

Gut brain axis: an insight into microbiota role in Parkinson's disease.

作者信息

Moustafa Sara Ayman, Mohamed Shrouk, Dawood Abdelhameed, Azar Jihan, Elmorsy Ekramy, Rizk Noura A M, Salama Mohamed

机构信息

Institute of Global Health and Human Ecology (IGHHE) Graduate Program, The American University in Cairo, New Cairo, 11835, Egypt.

Nanotechnology Graduate Program, The American University in Cairo, New Cairo, 11835, Egypt.

出版信息

Metab Brain Dis. 2021 Oct;36(7):1545-1557. doi: 10.1007/s11011-021-00808-2. Epub 2021 Aug 9.

DOI:10.1007/s11011-021-00808-2
PMID:34370175
Abstract

Parkinson's disease (PD) is one of the most common progressive neurodegenerative diseases. It is characterized neuropathologically by the presence of alpha-synuclein containing Lewy Bodies in the substantia nigra of the brain with loss of dopaminergic neurons in the pars compacta of the substantia nigra. The presence of alpha-synuclein aggregates in the substantia nigra and the enteric nervous system (ENS) drew attention to the possibility of a correlation between the gut microbiota and Parkinson's disease. The gut-brain axis is a two-way communication system, which explains how through the vagus nerve, the gut microbiota can affect the central nervous system (CNS), including brain functions related to the ENS, as well as how CNS can alter various gut secretions and immune responses. As a result, this dysbiosis or alteration in gut microbiota can be an early sign of PD with reported changes in short chain fatty acids, bile acids, and lipids. This gave rise to the use of probiotics and faecal microbiota transplantation as alternative approaches to improve the symptoms of patients with PD. The aim of this review is to discuss investigations that have been done to explore the gastrointestinal involvement in Parkinson's disease, the effect of dysbiosis, and potential therapeutic strategies for PD.

摘要

帕金森病(PD)是最常见的进行性神经退行性疾病之一。其神经病理学特征是大脑黑质中存在含有α-突触核蛋白的路易小体,同时黑质致密部的多巴胺能神经元丧失。黑质和肠神经系统(ENS)中α-突触核蛋白聚集体的存在,引发了人们对肠道微生物群与帕金森病之间相关性的关注。肠-脑轴是一个双向通信系统,它解释了肠道微生物群如何通过迷走神经影响中枢神经系统(CNS),包括与肠神经系统相关的脑功能,以及中枢神经系统如何改变各种肠道分泌物和免疫反应。因此,这种肠道微生物群的失调或改变可能是帕金森病的早期迹象,已有报道称短链脂肪酸、胆汁酸和脂质发生了变化。这促使人们使用益生菌和粪便微生物群移植作为改善帕金森病患者症状的替代方法。本综述的目的是讨论为探索帕金森病的胃肠道受累情况、失调的影响以及帕金森病的潜在治疗策略所开展的研究。

相似文献

1
Gut brain axis: an insight into microbiota role in Parkinson's disease.肠脑轴:深入了解微生物群在帕金森病中的作用
Metab Brain Dis. 2021 Oct;36(7):1545-1557. doi: 10.1007/s11011-021-00808-2. Epub 2021 Aug 9.
2
The role of gut dysbiosis in Parkinson's disease: mechanistic insights and therapeutic options.肠道菌群失调在帕金森病中的作用:机制见解和治疗选择。
Brain. 2021 Oct 22;144(9):2571-2593. doi: 10.1093/brain/awab156.
3
Microbiota- Brain-Gut-Axis Relevance to Parkinson's Disease: Potential Therapeutic Effects of Probiotics.肠道菌群-脑-肠轴与帕金森病的关系:益生菌的潜在治疗作用。
Curr Pharm Des. 2022;28(37):3049-3067. doi: 10.2174/1381612828666221003112300.
4
The Gut-Brain Axis: Two Ways Signaling in Parkinson's Disease.肠-脑轴:帕金森病中的双向信号传导
Cell Mol Neurobiol. 2022 Mar;42(2):315-332. doi: 10.1007/s10571-021-01066-7. Epub 2021 Mar 2.
5
Gut Microbial Metabolites in Parkinson's Disease: Implications of Mitochondrial Dysfunction in the Pathogenesis and Treatment.帕金森病中的肠道微生物代谢产物:线粒体功能障碍在发病机制和治疗中的意义。
Mol Neurobiol. 2021 Aug;58(8):3745-3758. doi: 10.1007/s12035-021-02375-0. Epub 2021 Apr 6.
6
Are We What We Eat? Impact of Diet on the Gut-Brain Axis in Parkinson's Disease.我们吃的东西决定了我们的身体吗?饮食对帕金森病的“肠-脑轴”的影响。
Nutrients. 2022 Jan 17;14(2):380. doi: 10.3390/nu14020380.
7
Gastrointestinal dysfunction in Parkinson's disease: molecular pathology and implications of gut microbiome, probiotics, and fecal microbiota transplantation.帕金森病的胃肠功能障碍:肠道微生物组、益生菌和粪便微生物移植的分子病理学及其意义。
J Neurol. 2022 Mar;269(3):1154-1163. doi: 10.1007/s00415-021-10567-w. Epub 2021 Apr 21.
8
Fecal microbiota transplantation protects rotenone-induced Parkinson's disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis.粪便微生物群移植通过抑制脂多糖-TLR4 信号通路介导的炎症反应,经由肠道菌群-肠-脑轴保护鱼藤酮诱导的帕金森病小鼠。
Microbiome. 2021 Nov 17;9(1):226. doi: 10.1186/s40168-021-01107-9.
9
Roles of α‑synuclein in gastrointestinal microbiome dysbiosis‑related Parkinson's disease progression (Review).α-突触核蛋白在胃肠道微生物组失调相关帕金森病进展中的作用(综述)。
Mol Med Rep. 2021 Oct;24(4). doi: 10.3892/mmr.2021.12374. Epub 2021 Aug 20.
10
Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson's Disease.肠道微生物群-脑-肠轴与帕金森病中的 Toll 样受体
Int J Mol Sci. 2018 Jun 6;19(6):1689. doi: 10.3390/ijms19061689.

引用本文的文献

1
Acupuncture for neurodegenerative diseases: mechanisms, efficacy, and future research directions.针灸治疗神经退行性疾病:作用机制、疗效及未来研究方向
Am J Transl Res. 2025 May 15;17(5):3703-3717. doi: 10.62347/QFJO6227. eCollection 2025.
2
Modulatory effects of traditional Chinese medicines on gut microbiota and the microbiota-gut-x axis.中药对肠道微生物群及微生物-肠-肝轴的调节作用
Front Pharmacol. 2024 Oct 9;15:1442854. doi: 10.3389/fphar.2024.1442854. eCollection 2024.
3
Citrobacter rodentium infection impairs dopamine metabolism and exacerbates the pathology of Parkinson's disease in mice.

本文引用的文献

1
Insight Into the Potential Value of Gut Microbial Signatures for Prediction of Gestational Anemia.洞悉肠道微生物特征预测妊娠期贫血的潜在价值。
Front Cell Infect Microbiol. 2021 Aug 30;11:734561. doi: 10.3389/fcimb.2021.734561. eCollection 2021.
2
New Avenues for Parkinson's Disease Therapeutics: Disease-Modifying Strategies Based on the Gut Microbiota.帕金森病治疗的新途径:基于肠道微生物群的疾病修饰策略。
Biomolecules. 2021 Mar 15;11(3):433. doi: 10.3390/biom11030433.
3
Gut microbiota: a potential therapeutic target for Parkinson's disease.
肠道沙门氏菌感染会损害多巴胺代谢,从而加剧小鼠帕金森病的病理。
J Neuroinflammation. 2024 Jun 7;21(1):153. doi: 10.1186/s12974-024-03145-0.
4
The Interaction Between Nutraceuticals and Gut Microbiota: a Novel Therapeutic Approach to Prevent and Treatment Parkinson's Disease.营养保健品与肠道微生物群的相互作用:预防和治疗帕金森病的新治疗方法。
Mol Neurobiol. 2024 Nov;61(11):9078-9109. doi: 10.1007/s12035-024-04151-2. Epub 2024 Apr 8.
5
Oral Administration of Inhibits the Permeability of Blood-Brain and Gut Barriers in a Parkinsonism Model.口服 可抑制帕金森病模型中血脑和肠道屏障的通透性。
Behav Neurol. 2023 Nov 9;2023:6686037. doi: 10.1155/2023/6686037. eCollection 2023.
6
Co-administration of Nanowired DL-3-n-Butylphthalide (DL-NBP) Together with Mesenchymal Stem Cells, Monoclonal Antibodies to Alpha Synuclein and TDP-43 (TAR DNA-Binding Protein 43) Enhance Superior Neuroprotection in Parkinson's Disease Following Concussive Head Injury.纳米载体 DL-3-正丁基苯酞(DL-NBP)与间充质干细胞、抗α-突触核蛋白和 TDP-43(TAR DNA 结合蛋白 43)单克隆抗体联合应用可增强创伤性脑损伤后帕金森病的卓越神经保护作用。
Adv Neurobiol. 2023;32:97-138. doi: 10.1007/978-3-031-32997-5_3.
7
Targeted metabolomic analysis in Parkinson's disease brain frontal cortex and putamen with relation to cognitive impairment.帕金森病脑额叶皮质和壳核中与认知障碍相关的靶向代谢组学分析
NPJ Parkinsons Dis. 2023 Jun 3;9(1):84. doi: 10.1038/s41531-023-00531-y.
8
An open label, non-randomized study assessing a prebiotic fiber intervention in a small cohort of Parkinson's disease participants.一项针对小队列帕金森病参与者的益生元纤维干预的开放性、非随机研究。
Nat Commun. 2023 Feb 18;14(1):926. doi: 10.1038/s41467-023-36497-x.
9
The pathobiological basis of depression in Parkinson disease: challenges and outlooks.帕金森病中抑郁的病理生物学基础:挑战与展望。
J Neural Transm (Vienna). 2022 Dec;129(12):1397-1418. doi: 10.1007/s00702-022-02559-5. Epub 2022 Nov 2.
10
Gut microbiota relieves inflammation in the substantia nigra of chronic Parkinson's disease by protecting the function of dopamine neurons.肠道微生物群通过保护多巴胺能神经元的功能来缓解慢性帕金森病黑质中的炎症。
Exp Ther Med. 2022 Jan;23(1):52. doi: 10.3892/etm.2021.10974. Epub 2021 Nov 16.
肠道微生物群:帕金森病的一个潜在治疗靶点。
Neural Regen Res. 2021 Feb;16(2):287-288. doi: 10.4103/1673-5374.290896.
4
Interaction between microbiota and immunity in health and disease.肠道菌群与免疫在健康与疾病中的相互作用。
Cell Res. 2020 Jun;30(6):492-506. doi: 10.1038/s41422-020-0332-7. Epub 2020 May 20.
5
Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease.肠道微生物组成和代谢与帕金森病的肠道功能有关。
Mov Disord. 2020 Jul;35(7):1208-1217. doi: 10.1002/mds.28052. Epub 2020 May 1.
6
Implications of the Gut Microbiome in Parkinson's Disease.肠道微生物组在帕金森病中的意义。
Mov Disord. 2020 Jun;35(6):921-933. doi: 10.1002/mds.28004. Epub 2020 Feb 24.
7
Dysbiosis in Parkinson's disease might be triggered by certain antibiotics.帕金森病中的肠道菌群失调可能由某些抗生素引发。
Med Hypotheses. 2020 Apr;137:109564. doi: 10.1016/j.mehy.2020.109564. Epub 2020 Jan 9.
8
Parkinson's disease: proteinopathy or lipidopathy?帕金森病:蛋白病还是脂类病?
NPJ Parkinsons Dis. 2020 Jan 3;6:3. doi: 10.1038/s41531-019-0103-7. eCollection 2020.
9
The Role of the Gut Microbiota in the Pathogenesis of Parkinson's Disease.肠道微生物群在帕金森病发病机制中的作用
Front Neurol. 2019 Nov 6;10:1155. doi: 10.3389/fneur.2019.01155. eCollection 2019.
10
Nigral overexpression of α-synuclein in a rat Parkinson's disease model indicates alterations in the enteric nervous system and the gut microbiome.黑质中α-突触核蛋白的过度表达表明肠道神经系统和肠道微生物组发生改变的大鼠帕金森病模型。
Neurogastroenterol Motil. 2020 Jan;32(1):e13726. doi: 10.1111/nmo.13726. Epub 2019 Oct 2.